EUVIMEDEUVIMED entdecken
Crossref

Immunostimulant In Situ Fibrin Gel for Post-operative Glioblastoma Treatment by Macrophage Reprogramming and Photo–Chemo-Immunotherapy

Ruotian Zhang, Yicheng Ye, Jianing Wu, Junbin Gao, Weichang Huang, Hanfeng Qin, Hao Tian, Mingyang Han, Boyan Zhao, Zhenying Sun, Xin Chen, Xingli Dong und 4 weitere

ACS Applied Materials & Interfaces · 2023

DOI: 10.1021/acsami.3c00468 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, 2023. Verfasst von Ruotian Zhang und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, The First Affiliated Hospital of Harbin Medical University, Harbin 150000, China. Hauptthemen laut MEDLINE: Glioblastoma. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 54 Literaturangaben. Gefördert von: Shenzhen Science and Technology Innovation Commission, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlioblastomaHumansAdjuvants, ImmunologicMacrophagesDoxorubicinImmunotherapyHydrogelsTumor MicroenvironmentCell Line, TumorDiazonium CompoundsPyridines

Stichwörter der Autor:innen

fibrin gelglioblastomamesoporous polydopaminenanovesicletumor-associated macrophage polarization

Substanzen

Adjuvants, ImmunologicDoxorubicinHydrogels3-(2'-pyridyldithio)benzyldiazoacetateDiazonium CompoundsPyridines

Autor:innen und Institutionen

  • Department of Neurosurgery, The First Affiliated Hospital of Harbin Medical University, Harbin 150000, China.
  • Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou 510515, China.
  • Shenzhen University General Hospital, Shenzhen 518000, China.
  • Sport Science College, Beijing Sport University, Beijing 100091, China.

ORCID-Profile: Yingfeng Tu

Förderung

  • Shenzhen Science and Technology Innovation Commission
  • National Natural Science Foundation of China

Zitieren

APA

Zhang, R., Ye, Y., Wu, J., Gao, J., Huang, W., Qin, H., Tian, H., Han, M., Zhao, B., Sun, Z., Chen, X., Dong, X., Liu, K., Liu, C., Tu, Y., & Zhao, S. (2023). Immunostimulant In Situ Fibrin Gel for Post-operative Glioblastoma Treatment by Macrophage Reprogramming and Photo–Chemo-Immunotherapy. ACS Applied Materials & Interfaces. https://doi.org/10.1021/acsami.3c00468

Vancouver

Zhang R, Ye Y, Wu J, Gao J, Huang W, Qin H, et al. Immunostimulant In Situ Fibrin Gel for Post-operative Glioblastoma Treatment by Macrophage Reprogramming and Photo–Chemo-Immunotherapy. ACS Applied Materials & Interfaces. 2023. doi:10.1021/acsami.3c00468

BibTeX
@article{Zhang2023,
  author = {Zhang, Ruotian and Ye, Yicheng and Wu, Jianing and Gao, Junbin and Huang, Weichang and Qin, Hanfeng and Tian, Hao and Han, Mingyang and Zhao, Boyan and Sun, Zhenying and Chen, Xin and Dong, Xingli and Liu, Kun and Liu, Chang and Tu, Yingfeng and Zhao, Shiguang},
  title = {Immunostimulant In Situ Fibrin Gel for Post-operative Glioblastoma Treatment by Macrophage Reprogramming and Photo–Chemo-Immunotherapy},
  journal = {ACS Applied Materials & Interfaces},
  year = {2023},
  doi = {10.1021/acsami.3c00468}
}
Kostenlos starten →